Adare Pharmaceuticals is a global specialty CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare’s proprietary technology platforms specialize in ODT, taste masking and customized drug release. To learn more, please visit us at www.AdarePharma.com
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
BASF offers comprehensive solutions to the pharmaceutical industry, ranging from a broad, high-quality excipients portfolio to chemical raw materials. With its expertise in polymer chemistry, its worldwide R&D-capabilities and the company’s commitment to developing value-adding excipients, BASF continuously creates solutions to challenges related to Instant-and-Modified-Release, Solubilization, Softgels, Skin-Delivery and Biologics
Established in 2005, Dolomite Microfluidics has grown to be the world leader in the design and manufacture of high quality innovative microfluidic products. The company offers a range of microfluidic systems, components and specialist chemicals – including pumps, chips, connectors, temperature controllers, sensors, accessories and custom-made components – as well as software for analysis or automation. Modularity, ease of use, innovation and scalability are common to all Dolomite Microfluidics products, which are used across a broad range of applications in biology, drug discovery, chemistry, food, cosmetics and academia. Dolomite is a part of the Blacktrace group of companies, a world leader in Productizing Science®, and has offices in the USA, Japan and Hanoi as well as a worldwide network of distributors.
Contract Drug Product R&D | Complex Injectable FormulationsDDE. Labs specializes in drug-device combination product development and integration with commercial strategy and life cycle plans. DDE Labs provides contract product development for parenteral solution formulations to complex injectables and has the expertise across formulation and delivery technologies.
Halozyme's proprietary ENHANZE® drug delivery technology is based on its patented recombinant human hyaluronidase enzyme (rHuPH20). Using rHuPH20 enables some biologics to be delivered rapidly in large volumes subcutaneously, which can potentially improve efficiencies for healthcare systems, reduce overall administration time and may reduce the treatment burden for patients.
MilliporeSigma, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. We offer pharmaceutical raw materials for formulation, a wide range of APIs and drug delivery compounds, including PEGs, lipids and PEG lipids. Our Emprove® Program provides extensive regulatory documentation to facilitate risk assessment and qualification processes.
Precision NanoSystems Inc (PNI) creates innovative solutions for the discovery, development and manufacture of medicines and medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body.
Recro Gainesville is the oral solid dose expert specializing in modified release technology, phase-appropriate formulation and analytical development, regulatory support, DEA controlled substances, and high potency compounds. Recro has the experts to deliver clients’ most complex pharmaceutical development and manufacturing projects in its best-in-class, 120,000 square feet of manufacturing space. For more information about Recro’s flexible CDMO solutions, visit www.recrogainesville.com.
At every stage—disease research, drug discovery/development, quality control, manufacturing—you need the right answers. All pharmaceuticals must undergo rigorous testing to ensure they are safe and effective. Agilent understands your workflows and has a comprehensive portfolio of sample-to-data solutions that work seamlessly together, providing accurate and reproducible results.
As a global leader in providing cellulose derivatives to the pharmaceutical industry, Ashland helps take the guesswork out of controlled release solutions. Our extensive product lines offer various degrees of both hydrophilicity and molecular weights, providing formulators with a host of options. The combination of our comprehensive product line, along with our passion and dedication to deliver solutions, results in the option to offer tailored release profiles that are designed to meet the needs of our customers’ drug molecules.
CureVac is a leading biotechnology company in the field of messenger RNA (mRNA) technology with expertise in developing and optimizing this versatile molecule for medical purposes. The principle of CureVac's technology is using mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting different diseases.
DigiM is the leader in characterizing pharmaceutical products with 3D micro-imaging analytics. We provide a one-stop image-based solution to help advance development of CR products, solid dosage forms, and delivery systems. Our quantitative analysis includes microstructure properties such as microporosity, dissolution, and diffusion.
Gattefossé provides excipients and drug delivery solutions to healthcare industries worldwide. Committed to advances in drug delivery and innovation, we stay current with the emerging needs and remain steadfast in sharing with customers our knowledge through a well-established network of services and technical support personnel in over 70 countries.
Biodegradable polymers optimized for use in sustained release delivery systems, including targeted delivery, nucleic acid administration, and more. We offer an extensive inventory, and substantial expertise in custom synthesis. LACTEL polymers are in numerous marketed pharmaceuticals approved by the FDA and others.
VCM (Vacuum-Compression-Molding) is a lossless screening approach dedicated to controlled release studies, ASDs, HME and lossless formulation screening. The Technology transforms thermoplastic materials in homogeneous specimens without altering the source materials’ characteristics. This novel method is designed as a fast, straight-forward and lossless process to meet demanding pharmaceutical requirements.
Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary microneedle patch technology that increases patient access to therapies by simplifying and improving the way actives are administered, stored, and distributed.
MyBiotech is a contract service organisation offering scale-up and downstream process development to its customers in the pharma and biotech industries. MyBiotech recently combined with MJR PharmJet in merger equals to acquire substantial expertise in the pharma sector, specialised in nanomedicine field, including analytics, product optimization, scale-up, formulation and GMP manufacturing. Combined company will drive technology oriented product innovation addressing the needs of the pharma and biotech fields.
NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbates 20 and 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid and gene delivery.
PTS designs and manufactures drug delivery platform based on biodegradable polyaminoacids. Our clients work in areas of targeted drug delivery, half-life extension, ADCs, nucleic acid delivery and payload protection from immunogenicity ("stealth technology"). Our state-of-the-art GMP manufacturing facility delivers high-quality materials combined with analytical characterozation at a very competitve price.
We are Sanofi, a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve human health. Every day we dedicate our most importatnt resource, our people, to support patients and families through their health journey.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes veterinary vaccines, medicines and diagnostics, which are complemented by genetic tests, biodevices and a range of services.“